AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 153 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $25,897,000 | +15.2% | 753,133 | 0.0% | 0.02% | +6.2% |
| Q3 2014 | $22,482,000 | +47.7% | 753,133 | -0.7% | 0.02% | +45.5% |
| Q2 2014 | $15,222,000 | -35.3% | 758,698 | -12.3% | 0.01% | -38.9% |
| Q1 2014 | $23,518,000 | +89.2% | 865,233 | +44.3% | 0.02% | +80.0% |
| Q4 2013 | $12,433,000 | +216.1% | 599,458 | +177.8% | 0.01% | +233.3% |
| Q3 2013 | $3,933,000 | +196550.0% | 215,766 | +215666.0% | 0.00% | – |
| Q2 2013 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,883,879 | $101,243,000 | 9.44% |
| Tamarack Capital Management, LLC | 1,250,000 | $25,913,000 | 6.14% |
| Healthcare Value Capital, LLC | 334,481 | $6,934,000 | 5.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,113,385 | $85,270,000 | 4.42% |
| KING INVESTMENT ADVISORS INC/TX | 312,890 | $6,486,000 | 2.96% |
| Broadfin Capital, LLC | 961,100 | $19,924,000 | 2.63% |
| SECTOR GAMMA AS | 462,504 | $9,588,000 | 2.59% |
| TAMRO Capital Partners LLC | 1,898,717 | $39,360,000 | 1.62% |
| Elk Creek Partners, LLC | 84,090 | $1,743,000 | 1.25% |
| Artal Group S.A. | 1,500,000 | $31,095,000 | 1.12% |